GLP-1 drugs show how quickly innovation can outpace policy, how cost pressures are resolved through access restrictions, and how deeply entrenched inequities shape who benefits from medical progress
Taking oral semaglutide was associated with a significantly lower risk of heart attack and stroke among participants compared with taking a placebo
Higuchi T, Abe M, Yamazaki T, Mizuno M, Okawa E, Ando H
Formononetin suppresses colitis-associated colon cancer by targeting lipid synthesis and mTORC2/Akt signaling
Kunutsor: conceptualization, methodology, data curation, formal analysis, investigation, original draft, writingreview and editing
Conclusion: The literature suggests anti-inflammatory effects of GLP-1RAs may provide direct benefit in the treatment of dermatologic conditions independent of glucose control in addition to indirect improvement via modulation of blood glucose and weight loss